TSHA - Taysha Gene Therapies, Inc.

QQQ $ 625.17 $ 0.00 (0 %)

DIA $ 480.61 $ 0.00 (0 %)

SPY $ 685.21 $ 0.00 (0 %)

TLT $ 89.81 $ 0.00 (0 %)

GLD $ 379.80 $ 0.00 (0 %)

Previous Close

$ 4.28

Open

$ 3.89

Bid

$ 4.25 x 5

Ask

$ 4.44 x 800

Day's Range

-- - --

52 Week Range

$ 1.05 - $ 5.51

Volume

5,042,003

Average Volume

Market Cap

1.17B

Beta (5Y Monthly)

$ 1.88

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-04-2025	09-30-2025	10-Q
2	08-12-2025	06-30-2025	10-Q
3	05-15-2025	03-31-2025	10-Q
4	02-26-2025	12-31-2024	10-K
5	11-13-2024	09-30-2024	10-Q
6	08-12-2024	06-30-2024	10-Q
7	05-14-2024	03-31-2024	10-Q
8	03-19-2024	12-31-2023	10-K
9	11-14-2023	09-30-2023	10-Q
10	08-14-2023	06-30-2023	10-Q
11	05-11-2023	03-31-2023	10-Q
12	03-28-2023	12-31-2022	10-K
13	11-08-2022	09-30-2022	10-Q
14	08-11-2022	06-30-2022	10-Q
15	05-16-2022	03-31-2022	10-Q
16	03-31-2022	12-31-2021	10-K
17	11-10-2021	09-30-2021	10-Q
18	08-16-2021	06-30-2021	10-Q
19	05-11-2021	03-31-2021	10-Q
20	03-03-2021	12-31-2020	10-K
21	11-12-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Citizens Maintains Market Outperform on Ta...
11/05/2025 12:51:47

Citizens analyst Silvan Tuerkcan maintains Taysha Gene Therapies (NASDAQ:TSHA) with a Market Outperform and raises the price...

Chardan Capital Maintains Buy on Taysha Ge...
11/05/2025 12:40:28

Chardan Capital analyst Geulah Livshits maintains Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and maintains $12 price tar...

Taysha Gene Therapies Q3 EPS $(0.09), Inli...
11/04/2025 11:58:57

Taysha Gene Therapies (NASDAQ:TSHA) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. Th...

Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

Raymond James Initiates Coverage On Taysha...
10/21/2025 17:43:52

Raymond James analyst Christopher Raymond initiates coverage on Taysha Gene Therapies (NASDAQ:TSHA) with a Strong Buy rating...

olema-pharmaceuticals-exelixis-genmab-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

Olema Pharmaceuticals, Exelixis, Genmab An...
10/20/2025 12:10:45

why-is-taysha-gene-therapies-stock-falling-friday

Why Is Taysha Gene Therapies Stock Falling...
10/17/2025 16:44:00

Taysha Gene Therapies shares fall after regaining full rights to Rett syndrome drug TSHA-102 and finalizing FDA alignment for p...

Needham Reiterates Buy on Taysha Gene Ther...
10/17/2025 10:37:03

Needham analyst Gil Blum reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and maintains $10 price target.

Taysha Gene Therapies Regains Full Rights ...
10/16/2025 20:06:34

DALLAS, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (NASDAQ:TSHA) (Taysha or the Company), a clinical-stage b...

Taysha Gene Announces Results From Supplem...
10/09/2025 12:04:56

Previously disclosed 100% response rate across all 10 patients in Part A for pivotal trial primary endpoint of gain/regain of ≥...

Demystifying Taysha Gene Therapies: Insigh...
10/02/2025 18:01:35

Baird Maintains Outperform on Taysha Gene ...
10/02/2025 17:52:42

Baird analyst Jack Allen maintains Taysha Gene Therapies (NASDAQ:TSHA) with a Outperform and raises the price target from $...

12 Health Care Stocks Moving In Thursday's...
10/02/2025 17:06:31

taysha-gene-therapies-canaan-ondas-holdings-and-other-big-stocks-moving-higher-on-thursday

Taysha Gene Therapies, Canaan, Ondas Holdi...
10/02/2025 16:29:57

U.S. stocks were mixed, with the Dow Jones index falling more than 50 points on Thursday.

Needham Maintains Buy on Taysha Gene Thera...
10/02/2025 14:51:58

Needham analyst Gil Blum maintains Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and raises the price target from $8 to $10.

top-2-health-care-stocks-that-may-keep-you-up-at-night-this-month

Top 2 Health Care Stocks That May Keep You...
10/02/2025 13:06:22

FDA Grants Breakthrough Therapy Designatio...
10/02/2025 12:03:48

Breakthrough Therapy designation granted based on FDA's review of available clinical evidence of safety and efficacy from a...

What's Driving the Market Sentiment Around...
09/18/2025 17:00:40

Is Taysha Gene Therapies Gaining or Losing...
08/25/2025 15:01:04

A Glimpse Into The Expert Outlook On Taysh...
08/13/2025 13:00:41